Huangshan Novel Co., Ltd. Class A

Huangshan Novel Co., Ltd. Class A

SSZSE:002014
11.04
CNY
+0.15
(+1.38%)
0.67EPS
15.83P/E
6.47BMarket Cap
Feb 09Next Earn
Huangshan Novel Co., Ltd. Class A
SZSE:002014
(Shenzhen Stock Exchange)

Recent

price

11.04

P/E

ratio

15.83

div

yld

9.98%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.61
3.07
2.84
2.75
2.82
3.08
3.13
3.34
3.88
4.35
4.59
4.98
5.46
5.55
5.73
6.12
6.31
Revenue per Share
0.25
0.3
0.33
0.3
0.26
0.32
0.33
0.34
0.37
0.45
0.51
0.52
0.6
0.67
0.76
0.72
0.67
Basic EPS, GAAP
0.09
0.1
0.08
-0.09
0.07
0.16
0.29
0.33
0.29
0.44
0.48
0.09
0.39
0.67
0.5
0.27
- -
Free Cash Flow per Basic Share
0.13
0.11
0.11
0.17
0.17
0.18
0.21
0.28
0.25
0.29
0.34
0.42
0.43
0.42
0.57
0.92
1.1
Dividend per Share
1.52
1.71
2.37
2.53
2.62
2.82
2.86
2.92
3.04
3.07
3.23
3.45
3.72
4.01
4.23
4.04
4.07
Book Value per Share
1.47
1.62
2.27
2.43
2.53
2.71
2.75
2.82
2.94
2.96
3.1
3.33
3.58
3.88
4.1
3.92
3.95
Tangible Book Value per Share
489
493
536
588
592
600
608
601
601
598
596
608
605
609
615
609
611
Basic Weighted Avg Shares
1,276
1,513
1,521
1,618
1,668
1,849
1,904
2,008
2,332
2,600
2,737
3,024
3,304
3,379
3,525
3,723
3,853
Sales/Revenue/Turnover
10.41
10.75
12.51
11.31
9.47
11.67
12.36
11.95
11.17
12.44
12.94
11.71
12.19
14.49
14.95
13.92
12.84
Operating Margin (%)
41
44
53
59
65
78
90
90
89
98
110
121
126
150
152
153
- -
Depreciation Expense
121
148
179
176
154
190
203
205
225
269
303
316
363
408
468
438
407
Net Income, GAAP
14.71
15
15.06
14.74
14.31
14.47
14.65
14.22
13.33
11.03
11.58
10.78
9.55
10.14
11.1
10.81
10.56
Effective Tax Rate (%)
9.5
9.77
11.75
10.89
9.26
10.28
10.65
10.23
9.66
10.35
11.07
10.45
10.98
12.08
13.27
11.77
10.57
Profit Margin (%)
407
397
903
907
862
891
984
1,046
1,054
1,008
1,029
1,048
1,077
1,264
1,420
1,464
1,346
Working Capital
- -
- -
- -
- -
- -
- -
11
11
11
11
- -
- -
46
115
130
219
222
LT Debt
771
866
1,414
1,506
1,561
1,681
1,756
1,796
1,873
1,895
2,031
2,171
2,325
2,505
2,637
2,524
2,543
Total Equity
15.19
16.36
14.08
11.28
9.28
11.32
11.39
11.67
12.06
14.18
14.91
14.21
14.38
13.72
13.89
12.38
11.26
Return on Invested Capital (%)
16.29
17.73
15.4
12.07
10.13
11.47
11.52
11.19
11.84
13.89
14.54
14.07
14.37
13.81
13.96
12.34
11.47
Return on Capital (%)
16.9
18.55
16.01
12.27
10.23
11.9
11.99
11.77
12.51
14.56
15.75
15.34
16.46
17.23
18.54
17.3
15.75
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
854
680
875
LT Borrowings
216
254
219
LT Finance Leases
3
3
3
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
612
612
612
Market Capitalization
7,301
7,264
6,468

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,019
2,841
2,942
Cash, Cash Equivalents & STI
1,631
1,362
1,424
Accounts Receivable, Net
699
702
710
Inventories
428
461
562
Total Current Liabilities
1,554
1,311
1,596
Payables & Accruals
- -
- -
- -
ST Debt
854
680
875
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.21%
4.54%
-4.25%
Free Cash Flow
39.51%
48.76%
-46.75%
Net Income, GAAP
8.96%
7.97%
-6.33%
Sales/Revenue/Turnover
7.33%
6.39%
5.61%
Total Cash Common Dividend
19.79%
24.61%
61.49%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
835
816
889
986
3,525
2025
848
898
- -
1,017
3,723
2026
940
998
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
0.15
0.2
0.27
0.76
2025
0.15
0.15
- -
0.21
0.72
2026
0.15
0.15
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.56
- -
- -
0.57
2025
0.01
0.64
- -
0.18
0.92
2026
- -
0.28
- -
- -
- -
Business
Huangshan Novel Co.,Ltd Huangshan Novel Co.,Ltd (002014.SZ) manufactures and sells plastic color-printing composite flexible packaging materials, vacuum metallized films, multi-functional high-barrier films, medical and pharmaceutical packaging materials, breathable and protective membranes, injection-molded packaging products, thermoformed blister materials, and printing inks; these high-tech products serve industries including food and dairy, pharmaceuticals, daily chemicals, agrochemicals, electronics, building materials, pet food, and aviation. Headquartered in Huangshan, Anhui Province, China, and founded in 1992 as a foreign-invested joint-stock company listed on the Shenzhen Stock Exchange SME board in 2004, the company operates subsidiaries such as Huangshan Packaging, Guangzhou Novel, Hebei Novel, Shaanxi Novel, Novel New Materials, and Xinli Ink across China, with an overseas office in Thailand and exports to Europe, the United States, Mexico, Japan, the Middle East, and Asia. It maintains research platforms including a National Enterprise Technology Center, Postdoctoral Workstation, and Anhui Province Engineering Technology Center, partnering with domestic institutions and global packaging firms like P&G, Nestle, and Colgate. In recent developments, Huangshan Novel deepens international collaborations through its Thailand office and overseas warehouses to expand exports amid RCEP implementation, achieving 18.84% overseas revenue growth in 2024 to 452 million yuan; it earned recognition as one of China's Top 100 Listed Companies for ESG performance in October 2024 and hosted its 2024 annual summary and 2025 mobilization conference in March 2025, emphasizing innovation in recyclable packaging and high-barrier films while advancing vertical integration via prior acquisitions like Xinli Ink in 2016.